A Targeted Approach for Immunoglobulin-A Nephropathy
Dr. Srinivasan will discuss the four hit pathogenic process of IgA nephropathy, including the role of galactose deficient immunoglobulin-A1 (Gd-IgA1) and A-proliferation inducing ligand (APRIL).
User experience form

Attend live and virtual events that provide a platform for education and collaborative discussion about the management of kidney disease and strategies to improve kidney health.
Any NephU member can request a presentation for their region or organization at no charge.
Dr. Srinivasan will discuss the four hit pathogenic process of IgA nephropathy, including the role of galactose deficient immunoglobulin-A1 (Gd-IgA1) and A-proliferation inducing ligand (APRIL).
This webinar will focus on the current biomarker landscape as well as novel biomarkers that are currently being studied. The webinar will also focus on why biomarkers are needed and what the unmet need is.
The goal of this webinar series is to review the 2025 KDIGO Clinical Practice Guideline for the Evaluation, Management, and Treatment of ADPKD.
The goal of this webinar series is to review the 2025 KDIGO Clinical Practice Guideline for the Evaluation, Management, and Treatment of ADPKD.
The goal of this webinar series is to review the 2025 KDIGO Clinical Practice Guideline for the Evaluation, Management, and Treatment of ADPKD.
This webinar will focus on the current biomarker landscape as well as novel biomarkers that are currently being studied. The webinar will also focus on why biomarkers are needed and what the unmet need is.
Notifications